Clinical Trials on Tuberculous Uveitis

Total 1871 results

Asan Medical Center

Completed

Isoniazid (INH) Treatment Based on ELISPOT Assay

Kidney Transplant Recipient

Korea, Republic of
University of Cape Town

Completed

Utility of Sputum Induction and Novel Technologies to Improve TB Diagnosis in a High HIV Prevalence Primary Care Setting (SINET)

Tuberculosis

South Africa
Dignitas International
University of Toronto; Ministry of Health and Population, Malawi

Completed

A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi

Tuberculosis

Malawi
Harvard School of Public Health (HSPH)
Muhimbili University of Health and Allied Sciences

Completed

Nutrition, Immunology and Epidemiology of Tuberculosis

Tuberculosis

United States
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Tuberculosis

United States, Canada
University Hospital, Bonn

Recruiting

Influence of Filarial Infections on Tuberculosis Disease and Tuberculosis Vaccination in Cameroon (MAP-TB)

Tuberculosis

Cameroon
Kilimanjaro Clinical Research Institute
European and Developing Countries Clinical Trials Partnership (EDCTP)

Completed

Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic (HighRif C)

Clinical Trial

Tanzania
Bill & Melinda Gates Medical Research Institute

Active, not recruiting

Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection

Tuberculosis

South Africa
University Hospital, Basel, Switzerland

Completed

Diagnosing of Acute Tuberculosis (SwEaTB)

Tuberculosis

Switzerland
Johns Hopkins University
Global Fund; National Tuberculosis Control Program, Pakistan

Completed

A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes

Smoking Cessation | Tuberculosis

Pakistan
Pfizer

Completed

Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)

Tuberculosis

Philippines
Makerere University

Completed

Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy (SAEFRIF)

Tuberculosis

Uganda
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women

Tuberculosis

Haiti, Kenya, Thailand, Malawi, Zimbabwe
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults

Tuberculosis

India
GlaxoSmithKline

Terminated

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease

Tuberculosis

Taiwan, Estonia
Johns Hopkins University
University of Witwatersrand, South Africa

Completed

Screening for TB in Pregnancy. on HIV-Infected Pregnant Women

Tuberculosis

South Africa
Aeras
European and Developing Countries Clinical Trials Partnership (EDCTP)

Completed

Study of AERAS-402 in Healthy Infants

Tuberculosis

Kenya, South Africa, Mozambique
National Institute of Allergy and Infectious Diseases...

Completed

Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination

Tuberculosis

South Africa
Dartmouth-Hitchcock Medical Center
Aeras

Completed

Phase I Trial of DAR-901

Tuberculosis

United States
Aeras
Statens Serum Institut

Completed

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404) (C-011-404)

Tuberculosis

South Africa
All India Institute of Medical Sciences, New Delhi

Completed

Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

Tuberculosis | Drug Induced Hepatotoxicity

India
Tuberculosis Research Centre, India
National Institutes of Health (NIH)

Recruiting

Comorbidities and Coinfections in Latent TB (COMBINE-TB)

Malnutrition | Latent Tuberculosis | Diabete Mellitus | Helminth Infection

India
Liverpool School of Tropical Medicine
REACH Ethiopia; Bingham University

Completed

A One-stop Shop for the Same Day Diagnosis and Management of TB and HIV

Tuberculosis | Hiv

Nigeria
Columbia University
United States Agency for International Development (USAID)

Completed

Start TB Patients on ART and Retain on Treatment (START Study) (START)

HIV | Tuberculosis

Lesotho
Dartmouth-Hitchcock Medical Center
National Institutes of Health (NIH)

Completed

Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis (DarDar)

HIV | Tuberculosis

Tanzania
The Aurum Institute NPC
London School of Hygiene and Tropical Medicine; Johns Hopkins University; Aurum...

Completed

Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals (WHIP3TB)

HIV | Tuberculosis

South Africa
University of Miami
Oswaldo Cruz Foundation

Terminated

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Tuberculosis | AIDS

Brazil
National Institute of Allergy and Infectious Diseases...

Terminated

Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research

HIV | Tuberculosis

Mali
Massachusetts General Hospital
Fogarty International Center of the National Institute of Health; Harvard University and other collaborators

Completed

Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda

HIV | Tuberculosis

Uganda
Lisichansk Regional Tuberculosis Dispensary
Ekomed LLC

Completed

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

HIV | Tuberculosis

Mongolia, Ukraine
Helen Reynolds
Liverpool University Hospitals NHS Foundation Trust

Completed

The Effect of Intermittent Rifampicin on Raltegravir (RIFRAL)

HIV | Tuberculosis

United Kingdom
Sequella, Inc.

Completed

Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults

Tuberculosis

United States
The Miriam Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Unknown

Rifampin and Efavirenz Interactions in Older Children

HIV | Tuberculosis

Ghana
The Miriam Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Unknown

Rifampin and Nevirapine Interactions in Young Children

HIV | Tuberculosis

Ghana
Bandim Health Project
Medical Research Council Unit, The Gambia; March of Dimes; International Cooperation... and other collaborators

Completed

Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?

Tuberculosis

Guinea-Bissau
Taipei Medical University WanFang Hospital

Unknown

Effectiveness of Music Therapy (TMT)

Tuberculosis

Taiwan
Armed Forces Capital Hospital, Republic of Korea

Completed

QuantiFERON Change During Anti-tuberculosis Medication

Tuberculosis | Interferon-gamma Release Assay

Korea, Republic of
Assiut University

Not yet recruiting

Sensitivity and Specificity of Xpert MTB/RIF Ultra

Tuberculosis
Indiana University
Regenstrief Institute, Inc.; Moi University; Kijani Consulting; Academic Model... and other collaborators

Completed

Clinical Decision-support Reminders to Improve IPT Initiation Among HIV Positive Adults in Western Kenya (TBTech)

Tuberculosis

Kenya
Columbia University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)

Tuberculosis

Lesotho
University of Cape Town
Medical Research Council; University of Stellenbosch; Rockefeller Foundation

Completed

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

Tuberculosis

South Africa
GlaxoSmithKline
Aeras

Completed

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Tuberculosis

Belgium
GlaxoSmithKline
Aeras

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents

Tuberculosis

South Africa
Massachusetts General Hospital
National Institute of Allergy and Infectious Diseases (NIAID); AIDS Healthcare...

Completed

Test and Treat TB: A Proof of Concept Trial in South Africa (Siyasiza)

Tuberculosis

South Africa
Aeras
Sanofi Pasteur, a Sanofi Company

Completed

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults (C-013-404)

Tuberculosis

Switzerland
Aeras

Completed

A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB (C-012-402)

Tuberculosis

Kenya
University of Cape Town
University of Zimbabwe; University of Zambia; NIMR - Mbeya Medical Research Programme

Completed

A Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients (LAMRCT)

Tuberculosis

Zambia, Zimbabwe, South Africa, Tanzania
Sanofi

Completed

Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients

Tuberculosis

United States
University of Stellenbosch
University of Pittsburgh

Unknown

TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial

Tuberculosis

South Africa
Vakzine Projekt Management GmbH
University of Stellenbosch; Children's Infectious Diseases Clinical Research... and other collaborators

Completed

Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa

Tuberculosis

South Africa

Clinical Trials on Tuberculous Uveitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations